BPC-157, TB-500, GHK-Cu, KPV and the GLOW and KLOW blends: what each is, the evidence, and the regulatory picture.
Copper tripeptide-1 · Glycyl-L-histidyl-L-lysine copper · GHK
Copper-binding tripeptide
A copper-binding tripeptide found naturally in blood and widely used in skincare. Lab results are strong; human trials are few and small, and none test injections.
Read moreBody Protection Compound 157 · PL 14736 · Bepecin · PCO-02
Synthetic 15-amino-acid peptide (gastric pentadecapeptide)
A 15-amino-acid peptide based on a stomach protein, popular for injury recovery. Strong results in rats, but only three small uncontrolled human pilot studies.
Read moreAc-LKKTETQ · Thymosin beta-4 fragment 17-23
Synthetic fragment of thymosin beta-4 (actin-binding peptide)
A synthetic 7-amino-acid fragment of thymosin beta-4, marketed for injury recovery. It has never been tested in a published human study.
Read moreForteo · Bonsity · PTH(1-34) · rhPTH(1-34) · Recombinant human parathyroid hormone 1-34 · Generic teriparatide
Parathyroid hormone analog (recombinant PTH 1-34)
A daily bone-building injection (PTH 1-34) approved since 2002 for osteoporosis at high fracture risk. In its main trial, new spine fractures fell from 14% on placebo to 5%, about a 65% relative reduction.
Read moreLys-Pro-Val · Lysine-proline-valine · alpha-MSH (11-13)
Anti-inflammatory tripeptide (melanocortin fragment)
A three-amino-acid fragment of alpha-MSH that reduced colitis in mice when taken by mouth. There are no published human studies.
Read moreTymlos · BA058 · PTHrP(1-34) analog · Abaloparatide-SC
Parathyroid hormone-related peptide (PTHrP 1-34) analog
A daily PTHrP-based bone-building injection approved in 2017 for postmenopausal osteoporosis and in 2022 for men. It cut new spine fractures by 86% versus placebo in ACTIVE.
Read moreSNAP-8 (Lipotec, now Lubrizol) · Acetyl octapeptide-3 · SNAP 8 · Snap8
Cosmetic neurotransmitter-inhibitor peptide (SNAP-25 mimic)
A cosmetic peptide sold as a topical 'Botox alternative.' Most of its anti-wrinkle data come from its manufacturer; independent studies have only tested it in mixed products.
Read moreL-alanyl-L-histidyl-L-lysine copper · AHK:Cu · AHK copper peptide
Copper-binding tripeptide
A synthetic copper-binding tripeptide related to GHK-Cu, sold in hair serums. It lengthened hair follicles in a lab study, but no human trials have been published.
Read moreCathelicidin · Human cathelicidin antimicrobial peptide (CAMP) · hCAP18 (precursor protein) · LL37 · Ropocamptide
Host-defense (antimicrobial) peptide
The only human cathelicidin, a natural antimicrobial peptide. Tested as a cream for leg ulcers with mixed results; not approved, and FDA has listed safety concerns for compounding.
Read more
GHK-Cu dosage in published studies: 2% serum and 0.4% cream on skin, animal injection doses, and why no human GHK-Cu injection dose or frequency exists.
BPC-157 side effects: what 30 people in human studies, FDA adverse event reports and animal toxicology show for the kidneys, liver, heart and blood pressure.
TB-500 side effects in people have never been studied. What FDA found, what thymosin beta-4 trials showed, the key risks, and who should avoid it.
The Wolverine stack pairs BPC-157 and TB-500 for injury recovery. What each peptide is, what research shows, side effects, FDA status and WADA rules.
The GLOW peptide blend combines GHK-Cu, BPC-157 and TB-500. What each does, the evidence for skin and healing, side effects, dosage and FDA status.
KLOW is the GLOW peptide blend plus KPV. What each ingredient does, KLOW vs GLOW, the evidence, side effects, dosage and FDA status as of 2026.
KPV dosage explained: no human dose has ever been studied. The amounts used in mouse colitis studies, why they don't convert to people, and FDA's 2026 review.
KPV side effects are unknown in people: FDA found no human studies, no toxicity tests and no adverse event reports. The real risks, from impurities to skin.
The best peptides for joint health, ranked by evidence: collagen peptides show small pain benefits, semaglutide helped knee arthritis, and BPC-157 is unproven.
KPV capsules are sold for gut inflammation. How oral KPV is absorbed, what mouse colitis studies found, why delivery matters, and why no human data exist yet.
The best peptides for wound healing, ranked by evidence: none is FDA-approved for wounds, LL-37 and pexiganan trials were mixed, and wound care comes first.
BPC-157 oral vs injectable compared: stomach stability, absorption, animal and human data for each route, safety, legal status and what is still unknown.
KPV cancer research is limited to mice: one study found fewer colitis-linked colon tumors. No human cancer data exist, and FDA found no safety studies of KPV.
TB-500 dosage explained: TB-500 itself has no human data. Thymosin beta-4 trials used 0.1% eye drops, 0.01-0.1% wound gels and 42-1,260 mg IV doses.
BPC-157 vs TB-500 for tendon, muscle and ligament injuries: how each works, the animal and human evidence, safety, FDA status and WADA rules in 2026.
Best peptides for gut health ranked by evidence: approved teduglutide, linaclotide and plecanatide first, then BPC-157, KPV and larazotide, which failed.
BPC-157 legal status in 2026: its 2023 Category 2 listing, April 2026 withdrawal, the July 2026 PCAC 8-6 vote, why it still can't be compounded, and WADA S0.
GHK-Cu side effects: what skin trials found for topical copper peptides, the immune, infection and liver concerns with injections, and copper limits.
The best peptides for tendon and ligament repair, by evidence: collagen peptides plus loading exercise have small trials; BPC-157 and TB-500 are animal-only.
Peptides vs stem cells for joints and injuries: how BPC-157 and TB-500 compare with stem cell injections on human evidence, safety, cost and 2026 FDA status.
GHK-Cu before and after results from real skin trials: what 12-week cream studies reported, the one published randomized trial, and the injection gap.
The best peptides for bone health are FDA-approved: teriparatide and abaloparatide cut fractures in trials. See how calcitonin and collagen peptides compare.
BPC-157 vs GHK-Cu compared: what each peptide does, human vs animal evidence for injuries and skin, side effects, copper safety and 2026 FDA status.
BPC-157 clinical trials in people: about 30 participants across three small uncontrolled studies, plus registered trials. What each found and what's next.
Peptides for scars and fibrosis, graded by evidence: GHK-Cu and thymosin beta-4 are mostly lab and animal data; silicone and steroid shots have trial support.
BPC-157 dosage in research: the few human doses tested (1 mg tablets to 20 mg IV), the animal doses behind most claims, and why no dose is approved.
Peptides vs PRP for tendon, joint and sports injuries: how BPC-157 and TB-500 compare with platelet-rich plasma on evidence, safety, cost and FDA status.
Peptides for post-surgery recovery, graded by evidence: BPC-157 and TB-500 rest on animal data, collagen has early trials, and your surgeon's plan comes first.
Best peptides for inflammation ranked by evidence: approved icotrokinra first, then KPV, BPC-157, thymosin beta-4 and LL-37, which rest mostly on animal data.
GHK-Cu research since 1973: strong lab and animal wound-healing data, one positive diabetic ulcer trial, and few human skin trials. What holds up today.
Antimicrobial peptides for wound healing: results from LL-37 leg ulcer trials, pexiganan's phase 3 failure, peceleganan spray and AMP dressings in development.
FDA updates and new research, explained in 5 minutes. Every week, free.
Enter your email to get The Beginner's Guide to Peptides, a free 10-page PDF: what peptides are, why everyone's talking about them, the popular names, and how to read quality documents like a COA.
Download the guide (PDF)